Nasal pharmaceutical formulations and methods of using the same

Details for Australian Patent Application No. 2010203026 (hide)

Owner Dey Pharma L.P.

Inventors Chaudry, Imtiaz

Agent Davies Collison Cave

Pub. Number AU-B-2010203026

Parent 2004229147

Filing date 16 July 2010

Wipo publication date 5 August 2010

Acceptance publication date 5 July 2012

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/7048

A61L 2/00 Disinfection or sterilising

Event Publications

5 August 2010 Application Open to Public Inspection

  Published as AU-B-2010203026

5 August 2010 Complete Application Filed

11 November 2010 Assignment before Grant

  Merck Patent GmbH The application has been assigned to Dey Pharma L.P.

5 July 2012 Application Accepted

  Published as AU-B-2010203026

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010203027-Surgical stapling apparatus

2010203025-Antisense modulation of PTP1B expression